COVID-19 and liver disease: mechanistic and clinical perspectives

T Marjot, GJ Webb, AS Barritt IV, AM Moon… - Nature reviews …, 2021 - nature.com
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …

Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services

K Søreide, J Hallet, JB Matthews… - Journal of British …, 2020 - academic.oup.com
Background The ongoing pandemic is having a collateral health effect on delivery of
surgical care to millions of patients. Very little is known about pandemic management and …

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

T Brevini, M Maes, GJ Webb, BV John, CD Fuchs… - Nature, 2023 - nature.com
Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-
converting enzyme 2 (ACE2), could represent a new chemoprophylactic approach for …

COVID-19 and the liver

D Jothimani, R Venugopal, MF Abedin… - Journal of …, 2020 - Elsevier
The current coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a major public health crisis …

[PDF][PDF] Clinical best practice advice for hepatology and liver transplant providers during the COVID‐19 pandemic: AASLD expert panel consensus statement

OK Fix, B Hameed, RJ Fontana, RM Kwok… - …, 2020 - Wiley Online Library
Background and Aims Coronavirus disease 2019 (COVID‐19), the illness caused by the
SARS‐CoV‐2 virus, is rapidly spreading throughout the world. Hospitals and healthcare …

Liver injury in COVID-19: The current evidence

SA Alqahtani, JM Schattenberg - United European …, 2020 - journals.sagepub.com
Patients with novel coronavirus disease 2019 (COVID-19) experience various degrees of
liver function abnormalities. Liver injury requires extensive work-up and continuous …

[HTML][HTML] COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients

JA Belsky, BP Tullius, MG Lamb, R Sayegh, JR Stanek… - Journal of Infection, 2021 - Elsevier
Background The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …

COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms

P Zhong, J Xu, D Yang, Y Shen, L Wang… - Signal transduction and …, 2020 - nature.com
Abstract Coronavirus disease-2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). The infection is spreading globally and poses a …

COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature

MA Raja, MA Mendoza, A Villavicencio, S Anjan… - Transplantation …, 2021 - Elsevier
Severe acute respiratory virus syndrome 2 (SARS-CoV-2) has led to a worldwide pandemic.
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …

COVID‐19 and liver disease—what we know on 1st May 2020

I Garrido, R Liberal, G Macedo - Alimentary pharmacology & …, 2020 - Wiley Online Library
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the
causative pathogen of coronavirus disease 2019 (COVID‐19), became a global threat to …